These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes. Tedesco FS Chromosome Res; 2015 Feb; 23(1):135-41. PubMed ID: 25596829 [TBL] [Abstract][Full Text] [Related]
5. Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy. Benedetti S; Uno N; Hoshiya H; Ragazzi M; Ferrari G; Kazuki Y; Moyle LA; Tonlorenzi R; Lombardo A; Chaouch S; Mouly V; Moore M; Popplewell L; Kazuki K; Katoh M; Naldini L; Dickson G; Messina G; Oshimura M; Cossu G; Tedesco FS EMBO Mol Med; 2018 Feb; 10(2):254-275. PubMed ID: 29242210 [TBL] [Abstract][Full Text] [Related]
6. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Kazuki Y; Hiratsuka M; Takiguchi M; Osaki M; Kajitani N; Hoshiya H; Hiramatsu K; Yoshino T; Kazuki K; Ishihara C; Takehara S; Higaki K; Nakagawa M; Takahashi K; Yamanaka S; Oshimura M Mol Ther; 2010 Feb; 18(2):386-93. PubMed ID: 19997091 [TBL] [Abstract][Full Text] [Related]
7. Transfer of human artificial chromosome vectors into stem cells. Oshimura M; Katoh M Reprod Biomed Online; 2008 Jan; 16(1):57-69. PubMed ID: 18252049 [TBL] [Abstract][Full Text] [Related]
8. Developing de novo human artificial chromosomes in embryonic stem cells using HSV-1 amplicon technology. Moralli D; Monaco ZL Chromosome Res; 2015 Feb; 23(1):105-10. PubMed ID: 25657030 [TBL] [Abstract][Full Text] [Related]
9. Transfer of Synthetic Human Chromosome into Human Induced Pluripotent Stem Cells for Biomedical Applications. Sinenko SA; Skvortsova EV; Liskovykh MA; Ponomartsev SV; Kuzmin AA; Khudiakov AA; Malashicheva AB; Alenina N; Larionov V; Kouprina N; Tomilin AN Cells; 2018 Dec; 7(12):. PubMed ID: 30544831 [TBL] [Abstract][Full Text] [Related]
10. [Challenge toward gene-therapy using iPS cells for Duchenne muscular dystrophy]. Oshimura M; Kazuki Y; Uno N Rinsho Shinkeigaku; 2012; 52(11):1139-42. PubMed ID: 23196542 [TBL] [Abstract][Full Text] [Related]
11. Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Tedesco FS; Hoshiya H; D'Antona G; Gerli MF; Messina G; Antonini S; Tonlorenzi R; Benedetti S; Berghella L; Torrente Y; Kazuki Y; Bottinelli R; Oshimura M; Cossu G Sci Transl Med; 2011 Aug; 3(96):96ra78. PubMed ID: 21849666 [TBL] [Abstract][Full Text] [Related]
12. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system. Yakura Y; Ishihara C; Kurosaki H; Kazuki Y; Komatsu N; Okada Y; Doi T; Takeya H; Oshimura M Biochem Biophys Res Commun; 2013 Feb; 431(2):336-41. PubMed ID: 23291180 [TBL] [Abstract][Full Text] [Related]
13. DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy. Park IH Mol Ther; 2010 Feb; 18(2):238-40. PubMed ID: 20125163 [No Abstract] [Full Text] [Related]
14. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y; Deng W Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934 [TBL] [Abstract][Full Text] [Related]
15. Stable maintenance of de novo assembled human artificial chromosomes in embryonic stem cells and their differentiated progeny in mice. Liskovykh M; Ponomartsev S; Popova E; Bader M; Kouprina N; Larionov V; Alenina N; Tomilin A Cell Cycle; 2015; 14(8):1268-73. PubMed ID: 25695642 [TBL] [Abstract][Full Text] [Related]
16. Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling. Kazuki Y; Uno N; Abe S; Kajitani N; Kazuki K; Yakura Y; Sawada C; Takata S; Sugawara M; Nagashima Y; Okada A; Hiratsuka M; Osaki M; Ferrari G; Tedesco FS; Nishikawa S; Fukumoto K; Takayanagi SI; Kunisato A; Kaneko S; Oshimura M; Tomizuka K Mol Ther Nucleic Acids; 2021 Mar; 23():629-639. PubMed ID: 33552683 [TBL] [Abstract][Full Text] [Related]
17. Refined human artificial chromosome vectors for gene therapy and animal transgenesis. Kazuki Y; Hoshiya H; Takiguchi M; Abe S; Iida Y; Osaki M; Katoh M; Hiratsuka M; Shirayoshi Y; Hiramatsu K; Ueno E; Kajitani N; Yoshino T; Kazuki K; Ishihara C; Takehara S; Tsuji S; Ejima F; Toyoda A; Sakaki Y; Larionov V; Kouprina N; Oshimura M Gene Ther; 2011 Apr; 18(4):384-93. PubMed ID: 21085194 [TBL] [Abstract][Full Text] [Related]
18. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380 [TBL] [Abstract][Full Text] [Related]
19. Highly Efficient Microcell-Mediated Transfer of HACs Containing a Genomic Region of Interest into Mammalian Cells. Liskovykh M; Larionov V; Kouprina N Curr Protoc; 2021 Sep; 1(9):e236. PubMed ID: 34491634 [TBL] [Abstract][Full Text] [Related]
20. A new generation of human artificial chromosomes for functional genomics and gene therapy. Kouprina N; Earnshaw WC; Masumoto H; Larionov V Cell Mol Life Sci; 2013 Apr; 70(7):1135-48. PubMed ID: 22907415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]